WO2001096372A3 - Zinc transporters proteins and their use in medicinal preparations - Google Patents
Zinc transporters proteins and their use in medicinal preparations Download PDFInfo
- Publication number
- WO2001096372A3 WO2001096372A3 PCT/GB2001/002597 GB0102597W WO0196372A3 WO 2001096372 A3 WO2001096372 A3 WO 2001096372A3 GB 0102597 W GB0102597 W GB 0102597W WO 0196372 A3 WO0196372 A3 WO 0196372A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- proteins
- zinc
- methods
- family
- disorders
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001264099A AU2001264099A1 (en) | 2000-06-13 | 2001-06-13 | Zinc transporters |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0014411A GB0014411D0 (en) | 2000-06-13 | 2000-06-13 | Zinc transporters |
GB0014411.3 | 2000-06-13 | ||
GB0014493A GB0014493D0 (en) | 2000-06-14 | 2000-06-14 | Zine transporters |
GB0014493.1 | 2000-06-14 | ||
US21634900P | 2000-07-05 | 2000-07-05 | |
US60/216,349 | 2000-07-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001096372A2 WO2001096372A2 (en) | 2001-12-20 |
WO2001096372A3 true WO2001096372A3 (en) | 2002-05-16 |
Family
ID=27255758
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2001/002597 WO2001096372A2 (en) | 2000-06-13 | 2001-06-13 | Zinc transporters proteins and their use in medicinal preparations |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001264099A1 (en) |
WO (1) | WO2001096372A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040141983A1 (en) | 1999-03-15 | 2004-07-22 | Protein Design Labs, Inc. | Compositions against cancer antigen LIV-1 and uses thereof |
EP1578364A4 (en) * | 2002-09-16 | 2011-06-08 | Genentech Inc | Compositions and methods for the treatmentof immune related diseases |
WO2004067564A2 (en) | 2003-01-29 | 2004-08-12 | Protein Design Labs, Inc. | Compositions against cancer antigen liv-1 and uses thereof |
WO2005063301A1 (en) * | 2003-12-26 | 2005-07-14 | Toshio Hirano | Emt inducer |
US7916304B2 (en) | 2006-12-21 | 2011-03-29 | Howard Hughes Medical Institute | Systems and methods for 3-dimensional interferometric microscopy |
JP6105481B2 (en) | 2010-12-06 | 2017-03-29 | シアトル ジェネティクス,インコーポレーテッド | Humanized antibodies against LIV-1 and their use for cancer therapy |
WO2014186587A1 (en) * | 2013-05-15 | 2014-11-20 | Syracuse University | Methods and systems for zinc delivery using intrinsic factor or haptocorrin |
MA45324A (en) | 2016-03-15 | 2019-01-23 | Seattle Genetics Inc | POLYTHERAPY USING ADC-LIV1 AND CHEMOTHERAPEUTIC AGENT |
-
2001
- 2001-06-13 AU AU2001264099A patent/AU2001264099A1/en not_active Abandoned
- 2001-06-13 WO PCT/GB2001/002597 patent/WO2001096372A2/en active Application Filing
Non-Patent Citations (4)
Title |
---|
DATABASE ENTREZ NUCLEOTIDE NCBI; 8 February 2001 (2001-02-08), GREEN, C ET AL.: "Human Breast Cancer, estrogen regulated LIV-1 protein (LIV-1) mRNA, complete cds.", XP002175107 * |
DATABASE ENTREZ NULCEOTIDE NCBI; 6 April 1996 (1996-04-06), GREEN, C ET AL.: "Human Breast Cancer, estrogen regulated LIV-1 protein (LIV-1) mRNA, partial cds.", XP002175106 * |
TAYLOR K M ET AL: "THE LIV-1 GENE, IMPLICATED IN METASTATIC BREAST CANCER, CODES FOR A HISTIDINE-RICH TRANSMEMBRANE PROTEIN", BRITISH JOURNAL OF CANCER, LONDON, GB, vol. 80, no. SUPPL 2, 11 July 1999 (1999-07-11), pages 24, XP001013344, ISSN: 0007-0920 * |
TAYLOR K M: "LIV-1 BREAST CANCER PROTEIN BELONGS TO NEW FAMILY OF HISTIDINE-RICHMEMBRANE PROTEINS WITH POTENTIAL TO CONTROL INTRACELLULAR ZN2+ HOMEOSTASIS", IUBMB LIFE, TAYLOR AND FRANCIS, LONDON,, GB, vol. 49, no. 4, April 2000 (2000-04-01), pages 249 - 253, XP001012651, ISSN: 1521-6543 * |
Also Published As
Publication number | Publication date |
---|---|
WO2001096372A2 (en) | 2001-12-20 |
AU2001264099A1 (en) | 2001-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Blesch et al. | Cloning of a novel malignant melanoma-derived growth-regulatory protein, MIA | |
WO2002054081A3 (en) | Proteins, genes and their use for diagnosis and treatment of kidney response | |
HRP20030547A8 (en) | Humanized antibodies that recognize beta amyloid peptide | |
WO2001040269A3 (en) | Compositions and methods for therapy and diagnosis of breast cancer | |
DE69922261D1 (en) | MONOCLONAL ANTIBODIES, ANTIGENS AND DIAGNOSIS AND THERAPY OF VICIOUS DISEASES | |
WO2000060076A3 (en) | Compositions for the treatment and diagnosis of breast cancer and methods for their use | |
WO2001000828A3 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
WO2001075454A3 (en) | Diagnosis and treatment of alzheimer's disease | |
ZA958444B (en) | Biological active proteins | |
WO2002059604A8 (en) | Diagnosis and treatment of multiple sclerosis | |
IL176076A0 (en) | Ligands,including antibodies showing, reactivity against endocrine cells | |
ATE132197T1 (en) | MONOCLONAL ANTIBODIES | |
WO2002088750A3 (en) | Proteins, genes and their use for diagnosis and treatment of breast cancer | |
AU9291198A (en) | Apoptosis-related compounds and their use | |
WO2001096372A3 (en) | Zinc transporters proteins and their use in medicinal preparations | |
WO2001049716A3 (en) | Compounds for immunotherapy and diagnosis of colon cancer and methods for their use | |
WO1997048804A3 (en) | Tie-2 receptor ligands (tie ligand-3; tie ligand-4) and their uses | |
Salamero et al. | Experimental autoimmune thyroiditis induced by a 5–10‐kDa tryptic fragment from porcine thyroglobulin | |
WO2000078960A3 (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
Smith et al. | Functional significance of gastrin gene expression in human cancer cells | |
CN101365469A (en) | Methods of treating obesity using enterostatin | |
RU2446174C2 (en) | Peptide with antiproliferative activity and pharmaceutical composition for treating proliferative diseases | |
Jha et al. | Prolonged retention of vaccinia virus complement control protein following IP injection: implications in blocking xenorejection | |
CA2123694A1 (en) | Peptides and antibodies for treatment of rheumatoid arthritis | |
WO2001083781A3 (en) | 14094, a novel human trypsin family member and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |